HEPATOBILIARY SCINTIGRAPHY FOR RISK ASSESSMENT OF POSTHEPATECTOMY LIVER FAILURE

Aim: to assess the role of hepatobiliary scintigraphy for prognosis of hepatic failure after liver resection; to determine threshold index of hepatic uptake of radioactive agent as an indication for surgical prevention of hepatic failure. Material and Methods. The study included 2 groups of patients who underwent hepatobiliary scintigraphy. The 1st group consisted of 50 patients with diffuse liver diseases (chronic hepatitis, liver cirrhosis) in whom histological examination of liver was performed according to METAVIR. 49 patients with liver tumors underwent advanced liver resections (over segments by Couinaud). Results. The highest median of hepatic uptake (2,86) was revealed in patients with liver fibrosis F1, the lowest (2,02) – in patients with liver fibrosis F4. Threshold value of hepatic uptake was 2,4. In 18 patients with hepatic uptake index <2,4 and remnant liver <40% surgical prevention of hepatic failure was performed: portal vein ligation (1), portal embolization (12), percutaneous embolization with radiofrequency ablation along the plane of future liver dissection (5). An increase of hepatic uptake index up to 2.7 ± 0.47 was revealed in the areas of liver regeneration and hypertrophy in 14–21 days after surgery. Conclusion. Combined static and dynamic hepatobiliary scintigraphy is valuable to assess volume and function of different liver segments. Threshold hepatic uptake index of 2.4 is sensitive to predict postoperative liver failure in case of future remnant liver <40%.

liver, hepatitis, cirrhosis, liver failure, liver cancer, resection, hepatobiliary scintigraphy

1. Вишневский В.А., Кубышкин В.А., Чжао А.В., Икрамов Р.З. Операции на печени. М., 2003. 155 с.Vishnevsky V.A., Kubishkin V.A., Chzhao A.V., Ikramov R.Z. Operacii na pecheni [Liver surgery]. Moscow, 2003. 155 р. (In Russian)

2. Poon R.T.P., Fan S.T., Lo C.M., Liu C.L., Lam C.M., Yuen W.K., Yeung C., Wong J. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann. Surg. 2002; 236 (5): 602–611. PMCID: PMC1422618.

3. Belghiti J., Hiramatsu K., Benoist S., Massault P., Sauvanet A., Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J. Am. Coll. Surg. 2000; 191 (1): 38–46. PMID: 10898182. DOI: 10.1016/s1072-7515(00)00261-1.

4. Das B.C., Isaji S., Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J. Surg. 2001; 25 (3): 266–272. PMID: 11343174. DOI: 10.1007/s002680020059.

5. Farges O., Malassagne B., Flejou J.F., Balzan S., Sauvanet A., Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a re-appraisal. Ann. Surg. 1999; 229 (2): 210–215. PMID: 10024102. PMCID: PMC1191633.

6. Nagino M., Kamiya J., Uesaka K., Sano T., Yamamoto H., Hayakawa N., Kanai M., Nimura Y. Complications of hepatectomy for hilarcholangiocarcinoma. World J Surg. 2001; 25 (10): 1277–1283. PMID: 11596890.

7. Yigitler C., Farges O., Kianmanesh R., Regimbeau J.M., Abdalla E.K., Belghiti J. The small remnant liver after major liver resection: how common and how relevant? Liver Transpl. 2003; 9 (9): S18–25. PMID: 12942474. DOI: 10.1053/jlts.2003.50194.

8. Farges O., Belghiti J., Kianmanesh R., Regimbeau J.M., Santoro R., Vilgrain V., Denys A., Sauvanet A. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann. Surg. 2003; 237 (2): 208–217. PMID: 12560779. PMCID: PMC1522143. DOI: 10.1097/01.SLA.0000048447.16651.7B.

9. Makuuchi M., Thai B.L., Takayasu K., Takayama T., Kosuge T., Gunven P., Yamazaki S., Hasegawa H., Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990; 107 (5): 521–527. PMID: 2333592.

10. Vauthey J.N., Chaoui A., Do K.A., Bilimoria M.M., Fenstermacher M.J., Charnsangavej C., Hicks M., Alsfasser G., Lauwers G., Hawkins I.F., Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000; 127 (5): 512–519. PMID: 10819059. DOI: 10.1067/msy.2000.105294.

11. Lau H., Man K., Fan S.T., Yu W.C., Lo C.M., Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br. J. Surg. 1997; 84 (9): 1255–1259.

12. Dinant S., de Graaf W., Verwer B.J., Bennink R.J., van Lienden K.P., Gouma D.J., van Vliet A.K., van Gulik T.M. Risk assessment of posthepatectomy liver failure using hepato-biliary scintigraphy and CT volumetry. J. Nucl. Med. 2007; 48 (5): 685–692. PMID: 17475954. DOI: 10.2967/jnumed.106.038430.

13. Wakabayashi H., Ishimura K., Okano K., Karasawa Y., Goda F., Maeba T., Maeta H. Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery. 2002; 131 (1): 26–33. PMID: 11812960.